Literature DB >> 19945358

Linking up and interacting with BRCT domains.

Felicity Z Watts1, Nigel C Brissett.   

Abstract

BRCT domains are present in an ever expanding family of proteins that includes many DNA repair and checkpoint proteins. The most prominent member of the BRCT family is BRCA1, mutations in which are responsible for a high proportion of breast and ovarian cancers. BRCT domains act as protein-protein interaction modules and facilitate the formation of hetero- and homo-oligomers. The domains occur either singly or in pairs, with up to eight domains in a single protein. When in pairs the domains are separated by a short inter-BRCT linker. Numerous crystal structures have been determined for BRCT domains from a range of different proteins, which indicate that the overall structure of the BRCT domains is generally well conserved. In contrast, the positions and structures of the linker regions are more varied, as are the roles of the linkers. Here, we describe the protein-protein interactions involving three different inter-BRCT linker regions, those of DNA ligase IV (LigIV), Schizosaccharomyces pombe Crb2 and human 53BP1. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945358     DOI: 10.1016/j.dnarep.2009.10.010

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  10 in total

1.  XLF regulates filament architecture of the XRCC4·ligase IV complex.

Authors:  Michal Hammel; Yaping Yu; Shujuan Fang; Susan P Lees-Miller; John A Tainer
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

Review 2.  BRCT domains: easy as one, two, three.

Authors:  Charles Chung Yun Leung; J N Mark Glover
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

3.  Structure of C-terminal tandem BRCT repeats of Rtt107 protein reveals critical role in interaction with phosphorylated histone H2A during DNA damage repair.

Authors:  Xinxin Li; Kaixian Liu; Fudong Li; Juncheng Wang; Hongda Huang; Jihui Wu; Yunyu Shi
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

4.  DNA binding and cleavage, BRCA1 gene interaction, antiglycation and anticancer studies of transition metal complexes of sulfonamides.

Authors:  Arusa Akhtar; Muhammad Danish; Awais Asif; Muhammad Nadeem Arshad; Abdullah M Asiri
Journal:  Mol Divers       Date:  2022-02-19       Impact factor: 2.943

5.  Mechanism of PhosphoThreonine/Serine Recognition and Specificity for Modular Domains from All-atom Molecular Dynamics.

Authors:  Yu-Ming M Huang; Chia-En A Chang
Journal:  BMC Biophys       Date:  2011-05-25       Impact factor: 4.778

6.  Structure and function of the Rad9-binding region of the DNA-damage checkpoint adaptor TopBP1.

Authors:  Mathieu Rappas; Antony W Oliver; Laurence H Pearl
Journal:  Nucleic Acids Res       Date:  2010-08-19       Impact factor: 16.971

7.  Effect of the novel Moroccan BRCA1 and BRCA2 frameshift mutations.

Authors:  Amal Tazzite; Hassan Jouhadi; Khalil Hamzi; Abdellatif Benider; Sellama Nadifi
Journal:  Indian J Hum Genet       Date:  2013-04

8.  Host Cell Reactivation and Transcriptional Activation of Carboplatin-Modified BRCA1.

Authors:  Adisorn Ratanaphan; Bhutorn Canyuk
Journal:  Breast Cancer (Auckl)       Date:  2014-03-23

Review 9.  Sister chromatid decatenation: bridging the gaps in our knowledge.

Authors:  Ronan Broderick; Wojciech Niedzwiedz
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 10.  A DNA repair BRCA1 estrogen receptor and targeted therapy in breast cancer.

Authors:  Adisorn Ratanaphan
Journal:  Int J Mol Sci       Date:  2012-11-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.